MRNS - Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.06 revenue of $7.34M beats by $1.03M
2023-11-07 07:07:28 ET
More on Marinus Pharmaceuticals
- Evaluating Marinus: Ztalmy's Growth And Upcoming Trial Insights
- Marinus Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Marinus Pharmaceuticals Q3 2023 Earnings Preview
- Marinus stock jumps 11% on financial, pipeline updates
For further details see:
Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.06, revenue of $7.34M beats by $1.03M